Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Clofazimine as a substitute for rifampicin improves efficacy of <i>Mycobacterium avium</i> pulmonary disease treatment …
Salillas S; Raaijmakers J; Aarnoutse RE; Svensson EM; Asouit K; van den Hombergh E; Te Brake L; Stemkens R; Wertheim HFL; Hoefsloot W; van Ingen J.
Antimicrob Agents Chemother
(Unknown)
Published: 2024
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacter…
Montelin H; Camporeale A; Hallgren A; Angelin M; Hogvall J; Östholm Balkhed Å; Vading M; Giske CG; Tängdén T; Swedish ESBL study group
.
J Antimicrob Chemother
(Unknown)
Published: 2024
Inhibition of <i>Pseudomonas aeruginosa</i> quorum sensing by chemical induction of the MexEF-oprN efflux pump.
Kristensen R; Andersen JB; Rybtke M; Jansen CU; Fritz BG; Kiilerich RO; Uhd J; Bjarnsholt T; Qvortrup K; Tolker-Nielsen T; Givskov M; Jakobsen TH.
Antimicrob Agents Chemother
(Unknown)
Published: 2024
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with …
Combrinck J; Tshavhungwe P; Rohlwink U; Enslin N; Thango N; Lazarus J; Kriegler K; Castel S; Abdelgawad N; Mcilleron H; Denti P; Wiesner L; Figaji A.
J Antimicrob Chemother
(Unknown)
Published: 2024
Loratadine Combats Methicillin-Resistant <i>Staphylococcus aureus</i> by Modulating Virulence, Antibiotic Resistance, a…
Viering BL; Balogh H; Cox CF; Kirpekar OK; Akers AL; Federico VA; Valenzano GZ; Stempel R; Pickett HL; Lundin PM; Blackledge MS; Miller HB.
ACS Infect Dis
(Unknown)
Published: 2023
Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective…
Bloch N; Rüfenacht S; Ludwinek M; Frick W; Kleger GR; Schneider F; Albrich WC; Flury D; Kuster SP; Schlegel M; Kohler P.
Antimicrob Resist Infect Control
(Unknown)
Published: 2023